Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.44
+0.41 (6.80%)
At close: May 8, 2026, 4:00 PM EDT
6.24
-0.20 (-3.11%)
After-hours: May 8, 2026, 7:59 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $39.85 million as of May 8, 2026. Its market cap has increased by 21.59% in one year.
Market Cap
39.85M
Enterprise Value
-10.70M
1-Year Change
21.59%
Ranking
Category
Stock Price
$6.44
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $39.85M, a decrease of -92.80%. That is a compound annual growth rate of -37.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 37.31M | -34.94% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 39.65M |
| Tvardi Therapeutics | 39.50M |
| Actinium Pharmaceuticals | 38.35M |
| Mereo BioPharma Group | 38.31M |
| INmune Bio | 38.02M |
| Palatin Technologies | 37.00M |
| NextCure | 36.72M |
| Veru Inc. | 36.27M |